DK159807C - Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber - Google Patents

Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber Download PDF

Info

Publication number: DK159807C
Authority: DK; Denmark
Prior art keywords: oil; calcium; weight; use according; composition
Prior art date: 1989-02-27

Application number

DK092689A

Other languages

Danish (da)

English (en)

Other versions

DK159807B (da

DK92689A (da

DK92689D0 (da

Inventor

Gunnar Kjems

Original Assignee

Gunnar Kjems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-27

Filing date

1989-02-27

Publication date

1992-06-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8099089&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK159807(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1989-02-27 Application filed by Gunnar Kjems filed Critical Gunnar Kjems

1989-02-27 Priority to DK092689A priority Critical patent/DK159807C/da

1989-02-27 Publication of DK92689D0 publication Critical patent/DK92689D0/da

1990-02-27 Priority to AT90904254T priority patent/ATE83664T1/de

1990-02-27 Priority to EP90904254A priority patent/EP0460080B1/de

1990-02-27 Priority to ES90904254T priority patent/ES2053183T3/es

1990-02-27 Priority to DK90904254.1T priority patent/DK0460080T3/da

1990-02-27 Priority to AU51833/90A priority patent/AU638001B2/en

1990-02-27 Priority to PCT/DK1990/000055 priority patent/WO1990009797A1/en

1990-02-27 Priority to DE9090904254T priority patent/DE69000663T2/de

1990-02-27 Priority to US07/761,364 priority patent/US5393535A/en

1990-02-27 Priority to JP2504132A priority patent/JP2784092B2/ja

1990-08-28 Publication of DK92689A publication Critical patent/DK92689A/da

1990-12-10 Publication of DK159807B publication Critical patent/DK159807B/da

1992-06-29 Publication of DK159807C publication Critical patent/DK159807C/da

1992-06-29 Application granted granted Critical

Links

239000011575 calcium Substances 0.000 title claims abstract description 23
206010037660 Pyrexia Diseases 0.000 title claims abstract description 16
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 13
229910052791 calcium Inorganic materials 0.000 title claims abstract description 13
239000003795 chemical substances by application Substances 0.000 title claims description 15
239000000839 emulsion Substances 0.000 title claims description 14
238000011282 treatment Methods 0.000 title claims description 9
230000002265 prevention Effects 0.000 title claims description 6
238000002360 preparation method Methods 0.000 title description 5
241000283690 Bos taurus Species 0.000 claims abstract description 24
239000000203 mixture Substances 0.000 claims abstract description 16
239000008346 aqueous phase Substances 0.000 claims abstract description 13
239000012071 phase Substances 0.000 claims abstract description 13
159000000007 calcium salts Chemical class 0.000 claims abstract description 6
239000007762 w/o emulsion Substances 0.000 claims abstract description 5
239000012875 nonionic emulsifier Substances 0.000 claims abstract 2
239000003921 oil Substances 0.000 claims description 17
235000019198 oils Nutrition 0.000 claims description 17
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical group [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 14
239000003995 emulsifying agent Substances 0.000 claims description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
239000003549 soybean oil Substances 0.000 claims description 9
235000012424 soybean oil Nutrition 0.000 claims description 9
239000001110 calcium chloride Substances 0.000 claims description 8
229910001628 calcium chloride Inorganic materials 0.000 claims description 8
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
206010006956 Calcium deficiency Diseases 0.000 claims description 4
239000003963 antioxidant agent Substances 0.000 claims description 4
239000003755 preservative agent Substances 0.000 claims description 4
239000000654 additive Substances 0.000 claims description 3
235000006708 antioxidants Nutrition 0.000 claims description 3
150000002148 esters Chemical class 0.000 claims description 3
239000000796 flavoring agent Substances 0.000 claims description 3
235000019634 flavors Nutrition 0.000 claims description 3
235000003599 food sweetener Nutrition 0.000 claims description 3
239000003765 sweetening agent Substances 0.000 claims description 3
235000019483 Peanut oil Nutrition 0.000 claims description 2
235000019484 Rapeseed oil Nutrition 0.000 claims description 2
229930003316 Vitamin D Natural products 0.000 claims description 2
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
235000014113 dietary fatty acids Nutrition 0.000 claims description 2
239000008157 edible vegetable oil Substances 0.000 claims description 2
239000000194 fatty acid Substances 0.000 claims description 2
229930195729 fatty acid Natural products 0.000 claims description 2
150000004665 fatty acids Chemical class 0.000 claims description 2
239000000312 peanut oil Substances 0.000 claims description 2
229920000223 polyglycerol Polymers 0.000 claims description 2
150000005846 sugar alcohols Polymers 0.000 claims description 2
239000011710 vitamin D Substances 0.000 claims description 2
235000019166 vitamin D Nutrition 0.000 claims description 2
150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
229940046008 vitamin d Drugs 0.000 claims description 2
125000004185 ester group Chemical group 0.000 claims 1
239000008169 grapeseed oil Substances 0.000 claims 1
229910052500 inorganic mineral Inorganic materials 0.000 claims 1
239000011707 mineral Substances 0.000 claims 1
235000010755 mineral Nutrition 0.000 claims 1
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract description 5
229910001424 calcium ion Inorganic materials 0.000 abstract description 5
238000000034 method Methods 0.000 abstract description 5
230000003902 lesion Effects 0.000 abstract description 3
235000013336 milk Nutrition 0.000 abstract description 3
239000008267 milk Substances 0.000 abstract description 3
210000004080 milk Anatomy 0.000 abstract description 3
210000002784 stomach Anatomy 0.000 abstract description 2
239000000499 gel Substances 0.000 description 14
229940043430 calcium compound Drugs 0.000 description 8
150000001674 calcium compounds Chemical class 0.000 description 8
235000011148 calcium chloride Nutrition 0.000 description 7
239000004354 Hydroxyethyl cellulose Substances 0.000 description 5
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 5
230000000694 effects Effects 0.000 description 5
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 5
239000000243 solution Substances 0.000 description 5
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
239000000047 product Substances 0.000 description 4
210000003815 abdominal wall Anatomy 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
230000002378 acidificating effect Effects 0.000 description 2
230000036528 appetite Effects 0.000 description 2
235000019789 appetite Nutrition 0.000 description 2
235000019658 bitter taste Nutrition 0.000 description 2
229940072020 calcium borogluconate Drugs 0.000 description 2
SSKRIDIHZLFJCG-UHFFFAOYSA-L calcium;2,3-dihydroxy-3-[2-hydroxy-5-(hydroxymethyl)-1,3,2-dioxaborolan-4-yl]propanoate Chemical compound [Ca+2].OCC1OB(O)OC1C(O)C(O)C([O-])=O.OCC1OB(O)OC1C(O)C(O)C([O-])=O SSKRIDIHZLFJCG-UHFFFAOYSA-L 0.000 description 2
244000309466 calf Species 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
235000021050 feed intake Nutrition 0.000 description 2
230000037406 food intake Effects 0.000 description 2
244000144980 herd Species 0.000 description 2
239000007788 liquid Substances 0.000 description 2
230000003449 preventive effect Effects 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
239000002562 thickening agent Substances 0.000 description 2
FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
235000019489 Almond oil Nutrition 0.000 description 1
244000144730 Amygdalus persica Species 0.000 description 1
229930194845 Bahia Natural products 0.000 description 1
235000008733 Citrus aurantifolia Nutrition 0.000 description 1
244000060011 Cocos nucifera Species 0.000 description 1
235000013162 Cocos nucifera Nutrition 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
206010021027 Hypomagnesaemia Diseases 0.000 description 1
244000147568 Laurus nobilis Species 0.000 description 1
235000017858 Laurus nobilis Nutrition 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
235000019482 Palm oil Nutrition 0.000 description 1
206010035669 Pneumonia aspiration Diseases 0.000 description 1
235000006040 Prunus persica var persica Nutrition 0.000 description 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
235000019486 Sunflower oil Nutrition 0.000 description 1
235000011941 Tilia x europaea Nutrition 0.000 description 1
206010044565 Tremor Diseases 0.000 description 1
244000290333 Vanilla fragrans Species 0.000 description 1
235000009499 Vanilla fragrans Nutrition 0.000 description 1
235000012036 Vanilla tahitensis Nutrition 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000008168 almond oil Substances 0.000 description 1
239000010775 animal oil Substances 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
201000009807 aspiration pneumonia Diseases 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
230000003185 calcium uptake Effects 0.000 description 1
239000004359 castor oil Substances 0.000 description 1
235000019438 castor oil Nutrition 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
230000007797 corrosion Effects 0.000 description 1
238000005260 corrosion Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000019621 digestibility Nutrition 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000005530 etching Methods 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
239000006052 feed supplement Substances 0.000 description 1
229940013317 fish oils Drugs 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
239000010651 grapefruit oil Substances 0.000 description 1
229920013819 hydroxyethyl ethylcellulose Polymers 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
230000000622 irritating effect Effects 0.000 description 1
230000006651 lactation Effects 0.000 description 1
239000004571 lime Substances 0.000 description 1
239000000944 linseed oil Substances 0.000 description 1
235000021388 linseed oil Nutrition 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
235000001055 magnesium Nutrition 0.000 description 1
230000007257 malfunction Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
229940029985 mineral supplement Drugs 0.000 description 1
235000020786 mineral supplement Nutrition 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
239000002540 palm oil Substances 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000008807 pathological lesion Effects 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000000902 placebo Substances 0.000 description 1
229940068196 placebo Drugs 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
210000004767 rumen Anatomy 0.000 description 1
229940085605 saccharin sodium Drugs 0.000 description 1
239000000523 sample Substances 0.000 description 1
239000011669 selenium Substances 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
235000011649 selenium Nutrition 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000002600 sunflower oil Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
230000002747 voluntary effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Fodder In General (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Feed For Specific Animals (AREA)

DK092689A 1989-02-27 1989-02-27 Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber DK159807C (da)

Priority Applications (10)

Application Number	Priority Date	Filing Date	Title
DK092689A DK159807C (da)	1989-02-27	1989-02-27	Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber
JP2504132A JP2784092B2 (ja)	1989-02-27	1990-02-27	牛のカルシウム欠乏症の予防ないし治療の方法
AT90904254T ATE83664T1 (de)	1989-02-27	1990-02-27	Oral verabreichbarer calciumzusatz fuer vieh.
EP90904254A EP0460080B1 (de)	1989-02-27	1990-02-27	Oral verabreichbarer calciumzusatz für vieh
ES90904254T ES2053183T3 (es)	1989-02-27	1990-02-27	Suplemento alimenticio que contiene calcio, de administracion oral, para el ganado.
DK90904254.1T DK0460080T3 (da)	1989-02-27	1990-02-27	Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvæg, især kælvningsfeber
AU51833/90A AU638001B2 (en)	1989-02-27	1990-02-27	Method for the prevention or treatment of calcium deficiency in cattle, in particular milk fever
PCT/DK1990/000055 WO1990009797A1 (en)	1989-02-27	1990-02-27	Orally administerable calcium supplement for cattle
DE9090904254T DE69000663T2 (de)	1989-02-27	1990-02-27	Oral verabreichbarer calciumzusatz fuer vieh.
US07/761,364 US5393535A (en)	1989-02-27	1990-02-27	Orally administerable calcium supplement for cattle

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK92689		1989-02-27
DK092689A DK159807C (da)	1989-02-27	1989-02-27	Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber

Publications (4)

Publication Number	Publication Date
DK92689D0 DK92689D0 (da)	1989-02-27
DK92689A DK92689A (da)	1990-08-28
DK159807B DK159807B (da)	1990-12-10
DK159807C true DK159807C (da)	1992-06-29

Family

ID=8099089

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK092689A DK159807C (da)	1989-02-27	1989-02-27	Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber
DK90904254.1T DK0460080T3 (da)	1989-02-27	1990-02-27	Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvæg, især kælvningsfeber

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK90904254.1T DK0460080T3 (da)	1989-02-27	1990-02-27	Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvæg, især kælvningsfeber

Country Status (9)

Country	Link
US (1)	US5393535A (de)
EP (1)	EP0460080B1 (de)
JP (1)	JP2784092B2 (de)
AT (1)	ATE83664T1 (de)
AU (1)	AU638001B2 (de)
DE (1)	DE69000663T2 (de)
DK (2)	DK159807C (de)
ES (1)	ES2053183T3 (de)
WO (1)	WO1990009797A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4402544C2 (de) *	1994-01-28	1996-01-18	Chevita Gmbh	Veterinärmedizinische Verwendung von Calciumformiat in Gel- oder Pastenform
US5560920A (en) *	1995-04-07	1996-10-01	The United States Of America, As Represented By The Secretary Of Agriculture	Calcium formulations for prevention of parturient hypocalcemia
US5962048A (en) *	1996-02-08	1999-10-05	Register; Jack W.	Veterinary pharmaceutical method of administration
US5958464A (en) *	1996-02-08	1999-09-28	Register; Jack W.	Veterinary pharmaceutical composition
WO1998002143A1 (en) *	1996-07-16	1998-01-22	Jørgen Kruuse A/S	An orally administrable, paste-like composition for veterinary use, a method for the preparation thereof, and the use of an oily vehicle for the manufacture of such composition
FR2760639B1 (fr) *	1997-03-14	2000-09-22	Innothera Lab Sa	Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable
WO1998049903A1 (en) *	1997-05-06	1998-11-12	Stuhr Enterprises, Inc.	Process for making an animal feed supplement
AU732598B2 (en) *	1997-07-25	2001-04-26	Board Of Regents For Oklahoma State University, The	Methods for improving meat tenderness and related meat products and feedstuffs
SE512089C2 (sv) *	1998-05-26	2000-01-24	Akzo Nobel Surface Chem	Sätt att framställa ett malt torrfoder med förutbestämd vattenhalt
US6262216B1 (en)	1998-10-13	2001-07-17	Affymetrix, Inc.	Functionalized silicon compounds and methods for their synthesis and use
DE60023122T2 (de) *	1998-10-30	2006-07-13	Rj Innovation	Verfahren zur Verhinderung von Hypokalzämie in gebährenden Tieren und hierfür verwendete Zusammensetzungen
US6355278B1 (en)	1999-03-31	2002-03-12	West Central Cooperative	Dry dairy cow supplement
US6160016A (en) *	1999-12-22	2000-12-12	Wisconsin Alumni Research Foundation	Phosphorus binder
JP2003518058A (ja) *	1999-12-22	2003-06-03	ウイスコンシンアラムナイリサーチフオンデーシヨン	リン結合剤および食物補助物として使用されるギ酸カルシウム
AU2002228500A1 (en) *	2000-12-21	2002-07-01	Massey University	Methods and compositions for reducing or preventing onset of milk fever
US20040202696A1 (en) *	2003-04-14	2004-10-14	Cts Chemical Industries Ltd.	Administration form for veterinary use
JP4614202B2 (ja) *	2004-08-04	2011-01-19	耕二三津田	乳熱の予防剤、乳熱の予防用飼料及び乳熱の予防方法
BR112014018530A8 (pt) *	2012-01-26	2017-07-11	Univ Cincinnati	Composições e métodos para aprimorar a lactação
FR3025104B1 (fr) *	2014-08-29	2017-11-24	Hy-Nutrition	Bolus a liberation immediate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE334766C (de) *	1919-09-28	1921-03-16	Hans Potratz	Verfahren zur Herstellung starker Kalksalzloesungen in Emulsionsform
US2198165A (en) *	1936-04-28	1940-04-23	Hamburger Lodewijk	Preparation containing calcium compounds
US3461203A (en) *	1964-12-28	1969-08-12	Leo Ab	Method for preventing puerperal paresis
DE1792410B2 (de) *	1967-09-01	1980-03-13	Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm	Arzneimittelzubereitung zur intravenösen Injektion
US4259323A (en) *	1980-03-24	1981-03-31	Hoffmann-La Roche Inc.	Potassium chloride emulsion
NL8401026A (nl) *	1983-11-09	1985-06-03	Unilever Nv	Eetbare w/o/w emulsie.

1989
- 1989-02-27 DK DK092689A patent/DK159807C/da not_active IP Right Cessation
1990
- 1990-02-27 DE DE9090904254T patent/DE69000663T2/de not_active Expired - Fee Related
- 1990-02-27 EP EP90904254A patent/EP0460080B1/de not_active Expired - Lifetime
- 1990-02-27 AT AT90904254T patent/ATE83664T1/de not_active IP Right Cessation
- 1990-02-27 AU AU51833/90A patent/AU638001B2/en not_active Expired
- 1990-02-27 WO PCT/DK1990/000055 patent/WO1990009797A1/en not_active Ceased
- 1990-02-27 JP JP2504132A patent/JP2784092B2/ja not_active Expired - Lifetime
- 1990-02-27 ES ES90904254T patent/ES2053183T3/es not_active Expired - Lifetime
- 1990-02-27 DK DK90904254.1T patent/DK0460080T3/da active
- 1990-02-27 US US07/761,364 patent/US5393535A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU5183390A (en)	1990-09-26
WO1990009797A1 (en)	1990-09-07
DK159807B (da)	1990-12-10
JP2784092B2 (ja)	1998-08-06
DK92689A (da)	1990-08-28
DK0460080T3 (da)	1993-05-03
ATE83664T1 (de)	1993-01-15
US5393535A (en)	1995-02-28
EP0460080B1 (de)	1992-12-23
ES2053183T3 (es)	1994-07-16
DE69000663D1 (de)	1993-02-04
EP0460080A1 (de)	1991-12-11
JPH04503670A (ja)	1992-07-02
DE69000663T2 (de)	1993-07-01
AU638001B2 (en)	1993-06-17
DK92689D0 (da)	1989-02-27

Legal Events

Date	Code	Title	Description
1996-10-14	PBP	Patent lapsed

Publication	Publication Date	Title
DK159807C (da)	1992-06-29	Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber
Goff et al.	1994	Calcium salts for treating hypocalcemia: carrier effects, acid-base balance, and oral versus rectal administration
JP2667351B2 (ja)	1997-10-27	食餌脂質消化吸収阻害剤および飲食品
AU2015347971B2 (en)	2019-12-19	Oral rehydration composition and methods thereof
IL93284A (en)	1994-11-28	A vibrant product for the preparation of an oral solution for rehydration
RS55145B1 (sr)	2016-12-30	Upotreba edta i njenih soli za prevenciju i tretiranje bakterijske intestinalne bolesti kod svinja
US6485738B1 (en)	2002-11-26	Delivery system for enhanced bioavailability of nutrients and supplements
DK169605B1 (da)	1994-12-27	Magnesiumadditiv til nærings-, foder- og lægemidler
US5631289A (en)	1997-05-20	Use of calcium formate in orally administrable compositions
US4497798A (en)	1985-02-05	Appetite suppressant
ES2283979T3 (es)	2007-11-01	Composicion enteral para la prevencion y/o tratamiento de sepsis.
WO2000054766A1 (en)	2000-09-21	Agents and methods for promoting production gains in animals
CN114144189B (zh)	2024-05-28	包含二甲基硅油和蔗糖酯的组合物及其作为消泡剂的用途
RU2667781C1 (ru)	2018-09-24	Биологически активная добавка из кедровой скорлупы и способ ее получения
RU2671635C1 (ru)	2018-11-06	Состав для стимуляции иммунометаболических процессов и профилактики диарейного синдрома новорожденных телят
Reid	1959	The treatment and prevention of bloat with anti–foaming agents
JPWO2017146141A1 (ja)	2018-12-13	水分補給用剤
WO2026049627A1 (en)	2026-03-05	Compositions for reducing lactation and improving health
CA3216014A1 (en)	2022-10-27	Nutritional supplement and uses
JPH0952845A (ja)	1997-02-25	保存安定性の高められた酵素含有内服液剤
Renney	2006	Oral fluid therapy for cows
WO2019140316A1 (en)	2019-07-18	Solid concentrated constipation treatment formulations
JP2019011279A (ja)	2019-01-24	下痢抑制剤
Malerba et al.	1997	O. 38 Protein-sparing therapy after major abdominal surgery: results of a prospective multicenter randomized study
AU2005200870A1 (en)	2005-03-24	Agents and methods for promoting production gains in animals